Jeff Harmon’s Post

View profile for Jeff Harmon

Inspiring a Movement to Redefine Limits and Achieve the Extraordinary || Champion for the Impossible

In the latest episode of "Conversations Life Science Leaders Aren't Having Today," Jeff welcomes Frank Knuettel II, the CEO of Chromocell Corporation, a company dedicated to developing innovative, non-addictive alternatives for pain treatment. Frank describes his excitement about being involved in the strategic planning at Chromocell, prioritizing projects, and exploring partnerships to maximize their resources. Jeff and Frank discuss the challenges and opportunities within the life sciences sector, particularly the need for innovative funding and the potential impact of price controls on drug development. The episode concludes with Frank expressing his concern about the potential loss of good science due to market downturns and stresses the need for ongoing innovation in pain management. Conversations Life Science Leaders Aren't Having is LIVE today on Spotify, Apple Podcasts, and YouTube.

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics